ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc (EGRX)

2.14
0.00
( 0.00% )
Updated: 19:00:00

Eagle Pharmaceuticals Inc Financial Summary

The current EGRX market cap is 27.79M. The company's latest EPS is USD 2.7444 and P/E is 0.78.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 213.31M195.89M187.8M171.55M316.61M
Operating Income 38.56M21.82M32.95M2.77M80.96M
Net Income 31.9M14.31M11.99M-8.63M35.64M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 238.6M254.55M253.19M253.73M406.16M
Total Liabilities 77.84M75.38M67.18M77.28M172.6M
Total Equity 160.76M179.17M186.01M176.45M233.56M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 52.38M55.99M49.5M28.22M50.7M
Investing -133k-777k-18.25M-5.32M-86.83M
Financing -88.12M-24.23M-37.87M-28.39M13.79M
Market Cap 27.79M
Price to Earnings Ratio 0.78
Price to Sales Ratio 0.09
Price to Cash Ratio 0.5
Price to Book Ratio 0.12
Dividend Yield -

Share Statistics

Shares Outstanding 12.99M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -68.06%
52 Week High 6.74
52 Week Low 1.80
Spread (Intraday) 0.03 (1.3%)

Company Info

Company Name Eagle Pharmaceuticals Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.eagleus.com
Industry pharmaceutical preparations (2834)